Routinely collected data for randomized trials: promises, barriers, and implications
Abstract Background Routinely collected health data (RCD) are increasingly used for randomized controlled trials (RCTs). This can provide three major benefits: increasing value through better feasibility (reducing costs, time, and resources), expanding the research agenda (performing trials for rese...
Main Authors: | Kimberly A. Mc Cord, Rustam Al-Shahi Salman, Shaun Treweek, Heidi Gardner, Daniel Strech, William Whiteley, John P. A. Ioannidis, Lars G. Hemkens |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-01-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-2394-5 |
Similar Items
-
Access to routinely collected health data for clinical trials – review of successful data requests to UK registries
by: Sarah Lensen, et al.
Published: (2020-05-01) -
Routinely collected patient data in neurology research: a systematic mapping review
by: Fran Biggin, et al.
Published: (2020-11-01) -
Multigenerational Health Research using Population-Based Linked Databases: An International Review
by: Naomi C. Hamm, et al.
Published: (2021-10-01) -
Accessing routinely collected health data to improve clinical trials: recent experience of access
by: Archie Macnair, et al.
Published: (2021-05-01) -
A preliminary study of real-time capturing and sharing of routine health data among the public health professionals
by: Raghavendra Ganiga, et al.
Published: (2020-01-01)